- A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation2011 | Second Faculty of Medicine
- Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)2014 | Second Faculty of Medicine
- Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR2015 | Second Faculty of Medicine
- Ivacaftor in adults with cystic fibrosis: a ten-year follow-pu of lung function and nutritional sttus2020 | Second Faculty of Medicine
- GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)2019 | Second Faculty of Medicine